VICE-PRESIDENT: Giovanni Damiani, Associate Professore, Dermatology, Center of Coordinated Research in Precision Medicine and Chronic Inflammation, University of Milan, Milan, Italy. Master's degree in Medicine and Surgery at the University of Brescia in 2013 (Mark: 110/110 with honor) with a thesis titled "Physio-pathological and clinical relevance of fraction of exhaled nitric oxide in psoriatic patients". Board in Dermatology and Venereology at the University of Milan in 2019 (Mark: 70/70) with a thesis titled "The metabolomic signature of non-lesional psoriatic skin: and advanced approach with artificial neural networks". Associate Professor in Dermatology at the University of Milan, with a PhD in Pharmacology (2020-2024) at the University of Padua (IT), a MSc in Pharmacovigilance, pharmacoepidemiology, pharmacoeconomics and real world evidence (2024-2025) at the University of Verona (IT), and two Postodcs in "Dermato-Immunology"(2018-2020) at Case Western Reserve University and "Immunology of Oral diseases" (2020-2022) at the University of Milan. As a Dermatologist, I strongly believe in the idea of "Physician Scientist" that combines clinical evidence and research to solve challenging cases. I built my expertise on pathogenesis and pharmacological treatments of cutaneous immune-mediated diseases (i.e. psoriasis, hidradenitis suppurativa and atopic dermatitis). My efforts concretized in 2019 in the Italian Center for Precision Medicine and Chronic Inflammation at the University of Milan in which different skills and professionists (i.e. biologists, bioinformaticians, doctors) collaborate to improve daily clinical practice through translational research.

Scrivi il tuo testo qui...

Chi Siamo

PRESIDENT: Gianluigi Ubaldo Mazzoccoli, Chronobiology Laboratory, Fondazione IRCCS Casa Sollievo della Sofferenza, Opera di Padre Pio da Pietrelcina, San Giovanni Rotondo, Italy. Master's degree in Medicine and Surgery at the University of Florence, Italy, in 1987. Board of Internal Medicine, University of Florence, Italy, in 1993. Since 1991 attending Physician and Researcher at the Department of Medical Sciences, Division of Internal Medicine, Scientific Institute and Regional General Hospital (IRCCS) “Casa Sollievo della Sofferenza”, Opera di Padre Pio da Pietrelcina, San Giovanni Rotondo, Italy. Since 2011 Research Leader of the Chronobiology Laboratory at the IRCCS “Casa Sollievo della Sofferenza”, Opera di Padre Pio da Pietrelcina, San Giovanni Rotondo, Italy. From 2011 to 2013 Visiting Scientist at the Institute of Hepatology, Foundation for Liver Research and Birkbeck College, University of London, UK. From 2014 to 2017 Visiting Scientist at the University College London, lnstitute for Liver and Digestive Health, Division of Medicine, The Royal Free Hospital, London, UK. Since 2022, Adjunct Professor for teaching of the Chronobiology Course at the Master's Degree Course in Medicine and Surgery of the University of Foggia, Italy. Since 2023, Adjunct Professor for teaching of Chronobiology at the Ph.D. Course in Basic and Clinical Neuroscience, Master's Degree Course in Molecular Biology, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy. Author of more than 200 papers in peer-reviewed international journals with more than 7000 citations. H index 42 (Scopus). Fields of interest and study: chronobiology, chronomedicine, genetics and genomics, oncology, immunology, endocrinology, pathophysiological mechanisms of aging, regenerative medicine, complex systems analysis, biological systems modeling.

TREASURER: Alberto Corsini is a Full Professor of Pharmacology at the Department of Pharmacological and Biomolecular Sciences at the University of Milan. His research focuses on atherogenesis and its pharmacological control, particularly on the properties of statins and other lipid-lowering agents in treating cardiovascular disease. Career and education Professor: He has been a Full Professor of Pharmacology at the University of Milan since 2005. Director: In 2017, he became the Director of the Department of Pharmacological and Biomolecular Sciences. Education: Corsini earned his Doctor of Pharmacy with distinction from the University of Milan in 1981, and later a PhD in Experimental Pharmacology in 1983. He also completed a PhD in Experimental Medicine (Atherosclerosis) from the University of Siena in 1990. Visiting Scientist: He served as a visiting scientist at the University of Washington in Seattle. Postdoctoral Researcher: From 1986 to 1987, he was a Postdoctoral Fellow at the Gladstone Foundation Laboratories for Cardiovascular Disease at the University of California, San Francisco. Research focus Atherosclerosis: His primary research interest is the study of atherogenesis—the process of plaque buildup in the arteries—and its pharmacological management. Lipid-lowering drugs: He investigates hypolipidemic agents and the properties of statins, including their effects on cardiovascular disease and atherosclerosis. His work also covers newer lipid-lowering agents, such as PCSK9 inhibitors and bempedoic acid. Drug comparisons: Recent work has explored the differential effects of traditional cigarettes, e-cigarettes, and heated tobacco products on vascular smooth muscle cells.